BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20070888)

  • 1. ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases.
    Gutwein P; Schramme A; Abdel-Bakky MS; Doberstein K; Hauser IA; Ludwig A; Altevogt P; Gauer S; Hillmann A; Weide T; Jespersen C; Eberhardt W; Pfeilschifter J
    J Biomed Sci; 2010 Jan; 17(1):3. PubMed ID: 20070888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.
    Gutwein P; Abdel-Bakky MS; Schramme A; Doberstein K; Kämpfer-Kolb N; Amann K; Hauser IA; Obermüller N; Bartel C; Abdel-Aziz AA; El Sayed el SM; Pfeilschifter J
    Am J Pathol; 2009 Jun; 174(6):2061-72. PubMed ID: 19435795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.
    Sachs M; Wetzel S; Reichelt J; Sachs W; Schebsdat L; Zielinski S; Seipold L; Heintz L; Müller SA; Kretz O; Lindenmeyer M; Wiech T; Huber TB; Lüllmann-Rauch R; Lichtenthaler SF; Saftig P; Meyer-Schwesinger C
    J Am Soc Nephrol; 2021 Jun; 32(6):1389-1408. PubMed ID: 33785583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
    Doberstein K; Pfeilschifter J; Gutwein P
    Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting ADAM10 in Renal Diseases.
    Wang JN; Cao XJ
    Curr Mol Med; 2023; 23(10):1037-1045. PubMed ID: 36278450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
    Lee SB; Schramme A; Doberstein K; Dummer R; Abdel-Bakky MS; Keller S; Altevogt P; Oh ST; Reichrath J; Oxmann D; Pfeilschifter J; Mihic-Probst D; Gutwein P
    J Invest Dermatol; 2010 Mar; 130(3):763-73. PubMed ID: 19865098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM10 promotes pituitary adenoma cell migration by regulating cleavage of CD44 and L1.
    Pan Y; Han C; Wang C; Hu G; Luo C; Gan X; Zhang F; Lu Y; Ding X
    J Mol Endocrinol; 2012 Aug; 49(1):21-33. PubMed ID: 22586143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. oxLDL-induced lipid accumulation in glomerular podocytes: role of IFN-γ, CXCL16, and ADAM10.
    Wang L; Sun S; Zhou A; Yao X; Wang Y
    Cell Biochem Biophys; 2014 Sep; 70(1):529-38. PubMed ID: 24752304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TspanC8 tetraspanins differentially regulate the cleavage of ADAM10 substrates, Notch activation and ADAM10 membrane compartmentalization.
    Jouannet S; Saint-Pol J; Fernandez L; Nguyen V; Charrin S; Boucheix C; Brou C; Milhiet PE; Rubinstein E
    Cell Mol Life Sci; 2016 May; 73(9):1895-915. PubMed ID: 26686862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity.
    Riedle S; Kiefel H; Gast D; Bondong S; Wolterink S; Gutwein P; Altevogt P
    Biochem J; 2009 May; 420(3):391-402. PubMed ID: 19260824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
    Yuan S; Lei S; Wu S
    Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
    Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
    Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. oxLDL promotes podocyte migration by regulating CXCL16, ADAM10 and ACTN4.
    Chen Y; Wang Z; Li Q; Yu L; Zhu Y; Wang J; Sun S
    Mol Med Rep; 2020 Sep; 22(3):1976-1984. PubMed ID: 32705248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma.
    Gaida MM; Haag N; Günther F; Tschaharganeh DF; Schirmacher P; Friess H; Giese NA; Schmidt J; Wente MN
    Int J Mol Med; 2010 Aug; 26(2):281-8. PubMed ID: 20596609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM10 mediates ectopic proximal tubule development and renal fibrosis through Notch signalling.
    Li B; Zhu C; Dong L; Qin J; Xiang W; Davidson AJ; Feng S; Wang Y; Shen X; Weng C; Wang C; Zhu T; Teng L; Wang J; Englert C; Chen J; Jiang H
    J Pathol; 2020 Nov; 252(3):274-289. PubMed ID: 32715474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adam10 is essential for early embryonic cardiovascular development.
    Zhang C; Tian L; Chi C; Wu X; Yang X; Han M; Xu T; Zhuang Y; Deng K
    Dev Dyn; 2010 Oct; 239(10):2594-602. PubMed ID: 20803506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of metalloproteinase ADAM10 in mantle cell lymphoma promotes cell growth and activates the TNFα/NFκB pathway.
    Armanious H; Gelebart P; Anand M; Belch A; Lai R
    Blood; 2011 Jun; 117(23):6237-46. PubMed ID: 21441465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling.
    Weber S; Niessen MT; Prox J; Lüllmann-Rauch R; Schmitz A; Schwanbeck R; Blobel CP; Jorissen E; de Strooper B; Niessen CM; Saftig P
    Development; 2011 Feb; 138(3):495-505. PubMed ID: 21205794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular endothelial cell maturation depends on ADAM10, a key regulator of Notch signaling.
    Farber G; Hurtado R; Loh S; Monette S; Mtui J; Kopan R; Quaggin S; Meyer-Schwesinger C; Herzlinger D; Scott RP; Blobel CP
    Angiogenesis; 2018 May; 21(2):335-347. PubMed ID: 29397483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
    Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.